Compass Wealth Management LLC Sells 475 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Compass Wealth Management LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 15,146 shares of the company’s stock after selling 475 shares during the quarter. Compass Wealth Management LLC’s holdings in HCA Healthcare were worth $4,546,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. MML Investors Services LLC lifted its holdings in HCA Healthcare by 31.7% during the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after purchasing an additional 4,285 shares during the last quarter. Meritage Group LP bought a new stake in shares of HCA Healthcare during the 3rd quarter worth about $150,548,000. Galvin Gaustad & Stein LLC bought a new position in HCA Healthcare in the 4th quarter valued at about $18,044,000. Alpha DNA Investment Management LLC acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $869,000. Finally, NRI Wealth Management LC bought a new stake in HCA Healthcare in the 4th quarter valued at $2,896,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HCA. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Barclays decreased their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. Morgan Stanley dropped their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.27.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 4.0 %

HCA opened at $312.51 on Friday. The company has a market cap of $79.16 billion, a P/E ratio of 14.03, a price-to-earnings-growth ratio of 1.09 and a beta of 1.64. The company has a fifty day moving average price of $313.49 and a two-hundred day moving average price of $352.62. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1-year low of $279.93 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.52% and a return on equity of 520.98%. During the same period in the previous year, the business posted $5.90 EPS. Analysts predict that HCA Healthcare, Inc. will post 21.75 EPS for the current fiscal year.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.